To examine the role of HSP60 oligomerization in cGAS/STING signaling and anti-tumor immunity, we aimed to determine whether the HSP60 mutant with defective oligomerization exhibits phenotypes similar to those observed in the methylation-defective mutant. The gene discussed is HSPD1; the disease is neoplasm.